• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Bardy Diagnostics

MedTech 100 roundup: Another peak for the industry

January 25, 2021 By Sean Whooley

Medtech stocks have been on the rise in 2021, and the past week saw the trend continue with yet another all-time best mark. MassDevice‘s MedTech 100 index reached 107.4 points on Jan. 20, topping the all-time best of 106.81 points set on Jan. 8. That mark represents a 16% jump from the pre-pandemic high of 92.32 […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, Amazon, Bardy Diagnostics, Boston Scientific, Cardiva Medical Inc., coronavirus, COVID-19, COVID-19 vaccine, GE Healthcare, Haemonetics, Hillrom, Intuitive Surgical, Joe Biden, MedTech 100 Index, Mesa Biotech, Obalon Therapeutics, Philips, Preventice, ReShape Lifesciences, Thermo Fisher Scientific

Hillrom to buy Bardy Diagnostics for $375M

January 19, 2021 By Chris Newmarker

Hillrom (NYSE:HRC) has agreed to spend $375 million to acquire Bardy Diagnostics and its Carnation Ambulatory Monitor, or CAM patch. Analysts at Baird described the CAM patch as a long-term Holter wearable biosensor. Hillrom said in a news release out today that the BardyDx purchase complements Hillrom’s present cardiology portfolio of cardiac stress exercise, Holter and […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Digital Health, Featured, Mergers & Acquisitions Tagged With: Bardy Diagnostics, Hillrom

Ambu, Boston Sci execs see domination for single-use scopes

September 11, 2020 By Tom Salemi

Hospital closures connected to COVID-19 have cut into the sales of many medical device companies, but executives at rival makers of single-use scopes say pandemic has only heightened existing concerns about contamination, exposure and cost. In interviews in this week’s DeviceTalks Weekly Podcast, executives from Ambu A/S  and Boston Scientific (NYSE:BSX)  said improved technology make […]

Filed Under: Endoscopic, Featured Tagged With: Ambu, Bardy Diagnostics, Boston Scientific, Centers for Medicare and Medicaid Services (CMS), CMS, Donald Trump, Elizabeth Holmes, Joe Biden, Kevin Hykes, Theranica Bio-Electronics, Theranos

The top 5 MassDevice stories of the week — September 11, 2020

September 11, 2020 By Chris Newmarker

From the Theranos case to wearable medical devices, it’s been another busy news week for the medical device industry. Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top Five: […]

Filed Under: Business/Financial News, Featured, Legal News, Pharmaceutical Tagged With: Bardy Diagnostics, coronavirus, COVID-19, Donald Trump, Elizabeth Holmes, Joe Biden, MassDevice Top Five, Theranica Bio-Electronics, Theranos

Bardy Diagnostics names new CEO

September 8, 2020 By Sean Whooley

Bardy Diagnostics announced that it appointed Kevin Hykes as its new president, CEO and member of its board effective Aug. 31, 2020. Hykes has more than 28 years of experience in the medical device industry, having served as president and CEO of Relievant Medical Systems, Metavention and Cameron Health. Additionally, Hykes held roles as an […]

Filed Under: Business/Financial News, Cardiovascular, Patient Monitoring Tagged With: Bardy Diagnostics, Personnel Moves

Bardy Diagnostics lands CE Mark for cardiac monitor patch

May 26, 2020 By Danielle Kirsh

Bardy Diagnostics this week said it received CE mark certification for its 14-day version of the Carnation Ambulatory Monitor patch. The patch is a P=wave centric ambulatory cardiac patch monitor and arrhythmia detection device. It gives clinicians more flexibility to monitor patients over a longer period of time while expanding the portfolio of the company’s […]

Filed Under: Cardiovascular, Patient Monitoring Tagged With: Bardy Diagnostics

Bardy Diagnostics’ patch could monitor coronavirus patients prescribed HCQ experimentally

March 26, 2020 By Sean Whooley

Bardy Diagnostics says Seattle-area health providers are using its Carnation ambulatory monitor (CAM) patch to measure QT segments in COVID-19 patients prescribed hydroxychloroquine (HCQ) experimentally. Hospitals across the city in their protocals have slated the local company’s CAM patch for use monitoring cardiac rhythms after coronavirus patients on HCQ are discharged from the hospital, as […]

Filed Under: Cardiac Implants, Cardiovascular, Diagnostics, Structural Heart Tagged With: Bardy Diagnostics, coronavirus, COVID-19

50 medtech startups you need to know

June 17, 2019 By Chris Newmarker

Medical device industry accelerator MedTech Innovator today announced about 50 medtech startups participating in its annual four-month program. Half are early-stage companies participating in MedTech Innovator’s Accelerator and Showcase program, and the other half are mid-stage companies in the organization’s Showcase program. The list of companies is a who’s who of people around the world […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Diabetes, Digital Health, Featured, Health Information Technology, News Well, Orthopedics, Software / IT Tagged With: Altratech, American BioOptics, Atro Medical, Avelas Biosciences, Avisi Technologies, Bardy Diagnostics, Bigfoot Biomedical, Bone Health Technologies, ClearCam, CloudCath, CoapTech, embolx, EndObetes, Epic Neuro, Flosonics Medical, Forest Devices, Glycotest, GNA Biosolutions, Halo Neuroscience, HD Medical, HealthReveal, Hepta Medical, Ischemia Care, Koya, Medasense Biometrics, Medtech Innovator, Moving Analytics, Nanomix, Olfactomics, OncoRes Medical, Onkos Surgical, Orbit Genomics, Patch’d, Potrero Medical, Previvo, Pristine Surgical, protembis, pyrames, Respirix, Savonix, Soletics, Starling Surgical, startups, Subtle Medical, Surgivisio, Thermopeutix, toSense, Vectorious, Venari Medical, ZKR Orthopedics

Bardy Diagnostics raises $36m in Series B

April 19, 2019 By Fink Densford

Bardy Diagnostics said this week that it raised $35.5 million in a round of Series B financing. The round was led by River Cities Capital Funds and joined by newly invested HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures and Rex Health Ventures. Existing investors SV Health Investors, Health Enterprise Partners and Ascension Ventures […]

Filed Under: Business/Financial News, Diagnostics, Wall Street Beat Tagged With: Bardy Diagnostics

11 pediatric cardiovascular devices you need to know about

September 25, 2018 By Nancy Crotti

A bandage-sized heart monitor, an extracorporeal blood pump that mimics the human heart, and a heart valve that can grow with a child were among the six winners of a contest in Philadelphia for innovative pediatric cardiovascular devices. The Pediatric Device Innovation Symposium organized by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National […]

Filed Under: Cardiac Implants, Cardiovascular, Implants, Pediatrics, Structural Heart Tagged With: AdvaMed, Bardy Diagnostics, cardiosounds, Circadiance, designmentor, draper, esperarefoundation, Flow Forward, NuPulseCV, pecalabs, polyvascular, pyrames, Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System

HRS 2018 Roundup: Device-related blood clots with Boston Scientific’s Watchman implant

May 11, 2018 By Brad Perriello

Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8

Filed Under: Cardiovascular Tagged With: Apple, Bardy Diagnostics, Boston Scientific, Fitbit, HRS 2018, Impulse Dynamics, Imricor Medical Systems Inc., medicalgorithmics, Medtronic, Preventice, samsung

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS